Evaluation of Effect of Seed Cycling on Anthropometric, Biochemical, Hormonal and Nutritional Parameters in the Women Diagnosed with Polycystic Ovarian Syndrome – A Cohort Interventional Study Design
Abstract
Background: Polycystic Ovary Syndrome (PCOS) is an endocrine disorder of reproductive age group in women and is characterized by obesity, hyper-insulinemia, hyperandrogenism and insulin resistance. Seed cycling has emerged as a potential treatment modality for managing PCOS symptoms. Methods: A total of 290 women diagnosed with PCOS, aged 18-40, and were enrolled in this study after meeting specific eligibility criteria. Participants were randomly divided into two groups: a control group (n=145) and an intervention group (n=145). The control group received a portion-controlled diet along with a daily dose of Metformin 500 mg for 12 weeks. The intervention group followed the same diet but incorporated seed cycling into their regimen. Assessments, including anthropometric measurements, biochemical analyses, hormonal evaluations, and nutritional assessments, were conducted at baseline and after the 12-week treatment period. The Mann-Whitney U test was used to compare outcomes between the two groups before and after treatment, with significance determined at p<0.05. Results: The majority of participants were aged 26-30 years (46.90%), with 60% being non-vegetarian. Among them, 36% were employed, and 14% engaged in physical activity. The intervention group demonstrated significant improvements in anthropometric, biochemical, and hormonal parameters compared to the control group. Notably, there was a decrease in mean energy consumption, carbohydrate intake, and fat intake in the…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 290 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.